Salvage radical prostatectomy: Refinement of an effective procedure

Seminars in Radiation Oncology

Volumn 13, Issue 2, 2003, Pages 166-174

  Pisters, Louis L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CONTRACTION; BRACHYTHERAPY; CRYOTHERAPY; HUMAN; INCONTINENCE; INTERMETHOD COMPARISON; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATECTOMY; REVIEW; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0037967359     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-4296(03)70010-1     Document Type: Review

References (25)

1. Pollack A, Zagars GK, Kavadai PS: Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer. Cancer 74:670-678, 1994
2. Lee WR, Hanks GE, Hanlon A: Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations. J Clin Oncol 15:230-238, 1997
3. Zagars GH, Pollack A, von Eschenbach AC: Prostate cancer and radiation therapy-the message conveyed by serum prostate-specific antigen. Int J Radiat Oncol Biol Phys 33:23-35, 1995
4. Chybowski FM, Keller L, Bergstralh EJ, et al: Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: Prostate specific antigen is superior to all other clinical parameters. J Urol 145:313-318, 1991
5. 111Indium-capromab pendetide labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy. J Clin Oncol 16:284-289, 1998
6. Kahn D, Williams RD, Manyak MJ, et al: In the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. J Urol 159:2041-2047, 1998
7. Amling CL, Lerner SE, Martin SK, et al: Deoxyribonucleic acid ploidy and serum prostate specific antigens predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol 161:857-862, 1999
8. Izawa JI, Perrotte P, Graham FG, et al: Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy. J Urol 165:867-870, 2001
9. Chin JL, Pautler SE, Mouraviev V, et al: Results of salvage cryoablation of the prostate after radiation: Identifying predictors of treatment failure and complications. J Urol 165:1937-1942, 2001
10. Cheng L, Sebo TJ, Slezak J, et al: Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy. Cancer 83(10): 2164-2171, 1998
11. Pisters LL, Perrotte P, Scott SM, et al: Patient Selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy. J Clin Oncol 17:2514-2520, 1999
12. Izawa JL, Madsen LT, Scott SM, et al: Salvage cryotherapy for recurrent prostate cancer after radiotherapy: Variables affecting patient outcome. J Clin Urol 20:2664-2671, 2002
13. Rogers E, Ohori M, Kassabian VS, et al: Salvage radical prostatectomy: Outcome measured serum prostate specific antigen levels. J Urol 153:104-110, 1995
14. Lerner SE, Blute ML, Zincke H: Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer. J Urol 154:1103-1109, 1995
15. Leibovich BC, Zincke H, Blute ML, et al: Recurrent prostate cancer after radiation therapy: Salvage prostatectomy versus salvage cryosurgery. American Urological Association, 96th Annual Meeting 165:1595, 2001
16. Wheeler JA, Zagars GK, Ayala AG: Dedifferentiation of locally recurrent prostate cancer after radiation therapy: Evidence for tumor progression. Cancer 71:3784-3787, 1993
17. Younes E, Haas GP, Montie JE: Value of preoperative PSA in predicting pathologic stage of patients undergoing salvage prostatectomy. Urology, 43:22-25, 1994
18. Ragde H, Elgamal AA, Snow PB, et al: Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer 83:989-1001, 1998
19. Garzotto M, Wajsman Z: Androgen deprivation with salvage surgery for radio recurrent prostate cancer: Results at 5-year follow-up. J Urol 159:950-955, 1998
20. Grado GL, Collins JM, Kriegshauser JS, et al: Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 53:2-10, 1999
21. Martins FE, Boyd SD: Post-operative risk factors associated with artificial urinary sphincter infection-erosion. Br J Urol 75:354-358, 1995
22. Martins FE, Bennett CJ, Dunn M, et al: Adverse prognostic features of collagen injection therapy for urinary incontinence following radical retro pubic prostatectomy. J Urol 158:1745-1749, 1997
23. Milam DF, Franke JJ: Prevention and treatment of incontinence after radical prostatectomy. Semin Urol Oncol 13:224-237, 1995
24. Pisters LL, English SF, Scott SM, et al: Salvage prostatectomy with continent catheterizable urinary reconstruction: A novel approach to recurrent prostate cancer after radiation therapy. J Urol 163:1771-1774, 2000
25. Monti, PR, Lara RC, Dutra MA, et al: New techniques for construction of efferent conduits based on the Mitrofanoff principle. Urology 49:112, 1997